Gulf International Bank UK Ltd maintained its stake in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 101,706 shares of the medical research company’s stock at the end of the second quarter. Gulf International Bank UK Ltd’s holdings in Agilent Technologies were worth $6,032,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the stock. BlackRock Inc. raised its stake in shares of Agilent Technologies by 1,946.9% in the first quarter. BlackRock Inc. now owns 23,119,219 shares of the medical research company’s stock valued at $1,222,310,000 after buying an additional 21,989,739 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Agilent Technologies by 31.4% in the first quarter. JPMorgan Chase & Co. now owns 8,366,511 shares of the medical research company’s stock valued at $442,338,000 after buying an additional 1,999,376 shares in the last quarter. MARSHALL WACE ASIA Ltd bought a new stake in shares of Agilent Technologies during the first quarter valued at approximately $58,065,000. Marshall Wace North America L.P. bought a new stake in shares of Agilent Technologies during the first quarter valued at approximately $58,065,000. Finally, FMR LLC raised its stake in shares of Agilent Technologies by 3.9% in the first quarter. FMR LLC now owns 21,588,407 shares of the medical research company’s stock valued at $1,141,379,000 after buying an additional 803,993 shares in the last quarter.
Shares of Agilent Technologies, Inc. (NYSE A) traded up 0.64% during midday trading on Friday, hitting $61.25. The company’s stock had a trading volume of 2,357,872 shares. The company has a 50-day moving average price of $60.30 and a 200 day moving average price of $56.14. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $62.42. The company has a market cap of $19.72 billion, a P/E ratio of 31.59 and a beta of 1.30.
Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.07. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. During the same period last year, the company posted $0.49 EPS. The business’s quarterly revenue was up 6.7% on a year-over-year basis. On average, equities research analysts predict that Agilent Technologies, Inc. will post $2.31 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This piece of content was published by BNB Daily and is the property of of BNB Daily. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.baseball-news-blog.com/2017/08/19/gulf-international-bank-uk-ltd-has-6032000-position-in-agilent-technologies-inc-nysea-updated-updated-updated.html.
A number of research firms have commented on A. Morgan Stanley reissued an “overweight” rating on shares of Agilent Technologies in a research note on Monday, July 10th. Jefferies Group LLC boosted their price objective on Agilent Technologies from $59.00 to $66.00 and gave the stock a “buy” rating in a research note on Tuesday, May 23rd. Deutsche Bank AG reissued a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a research note on Thursday, June 22nd. BTIG Research boosted their price objective on Agilent Technologies from $57.00 to $65.00 and gave the stock a “buy” rating in a research note on Wednesday, May 24th. Finally, Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 price objective on the stock in a research note on Tuesday, May 16th. Three analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Agilent Technologies has an average rating of “Buy” and an average price target of $62.55.
In related news, insider Mark Doak sold 21,851 shares of the business’s stock in a transaction dated Tuesday, May 30th. The stock was sold at an average price of $60.00, for a total value of $1,311,060.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Patrick Kaltenbach sold 2,074 shares of the business’s stock in a transaction dated Wednesday, May 31st. The shares were sold at an average price of $60.43, for a total value of $125,331.82. Following the completion of the sale, the insider now directly owns 42,212 shares of the company’s stock, valued at $2,550,871.16. The disclosure for this sale can be found here. Over the last three months, insiders sold 125,615 shares of company stock valued at $7,543,943.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.